Industry Advocacy

CHPA calls for new drug path for CBD, dietary ingredient status
Ahead of the Food and Drug Administration’s planned public hearing about cannabis, the Consumer Health Products Association is sharing its position on how it thinks the agency should view CBD.
CRN opens membership to CBD companies
The dietary supplement and functional food trade group’s board has voted to open up membership to companies marketing hemp-derived CBD and full-spectrum hemp extract in food and dietary supplements.

CREATES Act passes House Committee

The House Energy and Commerce Committee voted 51-0 to pass the CREATES Act of 2019.
Congress members report back to constituents about NACDS RxImpact Day

Members of Congress are reporting to their constituents about discussions they had on DIR fees and opioids as part of NACDS RXImpact Day on Capitol Hill.
NACDS to Senate Finance Committee: Finalize DIR fee reform

In addition to DIR fee reform, NACDS also is urging the development of standardized pharmacy quality metrics.
AAM raises concern over Trump budget's potential exclusivity changes

The Association for Accessible Medicines criticized the Administration's proposal to amend the 180-day period of exclusivity for first generics.
NACDS’ Anderson urges DIR fee reform in op-ed

NACDS president and CEO Steve Anderson emphasized DIR fee reform’s role in lowering patients’ out of pocket costs and reducing overall healthcare costs in a Morning Consult op-ed.
NACDS RxImpact Day highlights patient, pharmacy advocacy issues

Pharmacy advocates from all 50 states reached every congressional office during NACDS RxImpact Day.
FDA commissioner Gottlieb resigns

Food and Drug Administration commissioner Scott Gottlieb will leave the agency next month after serving in this role for nearly two years.
Walmart focuses on reducing private brands’ plastic waste

Walmart’s new initiatives are aimed at advancing the sustainability of the retailer’s private brand packaging and promoting consumer-friendly recycling labels.

CHPA calls for new drug path for CBD, dietary ingredient status

CRN opens membership to CBD companies

CREATES Act passes House Committee

Congress members report back to constituents about NACDS RxImpact Day

NACDS to Senate Finance Committee: Finalize DIR fee reform

AAM raises concern over Trump budget's potential exclusivity changes

NACDS’ Anderson urges DIR fee reform in op-ed

NACDS RxImpact Day highlights patient, pharmacy advocacy issues

FDA commissioner Gottlieb resigns

Walmart focuses on reducing private brands’ plastic waste